Belize vs Jordan: Previously treated cases tested for RR-/MDR-TB
Belize
100.0%
in 2024
Jordan
100.0%
in 2024
Belize rank
1st
Jordan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Belize
- Jordan
How they compare
Belize currently reports 100.0% against 100.0% in Jordan, a difference of 0.0%.
The two have swapped places 6 times across 15 shared years of data; in 2005 it was Jordan ahead.
Belize ranks 1st and Jordan ranks 1st of 180 countries.
Across the 3 decades both report, Belize averaged higher in 1 and Jordan in 2.
Head to head by decade
| Decade | Belize | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.0% | 67.5% | 57.5% | Jordan |
| 2010s | 35.6% | 36.6% | 1.0% | Jordan |
| 2020s | 91.6% | 58.4% | 33.2% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Belize or Jordan?
- Belize, at 100.0% against 100.0% in Jordan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Belize and Jordan?
- 0.0%, with Belize ahead.
- How many years of comparable data are there for Belize and Jordan?
- 15 years are reported by both, from 2005 to 2024.
- How do Belize and Jordan rank globally for previously treated cases tested for rr-/mdr-tb?
- Belize ranks 1st and Jordan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.